Dr. Peter Attia Recommends HRT For Women
Hormone Replacement Therapy (HRT) has been a hot topic, particularly in relation to women's health during perimenopause and menopause. Dr. Peter Attia, a renowned longevity expert, provides a comprehensive perspective on why he recommends HRT for women, shedding light on the physiological changes women undergo during these stages and the potential benefits of HRT.
The Context of Menopause and Perimenopause
When women transition into menopause, levels of sex hormones estrogen and progesterone significantly decrease. This hormonal shift triggers vasomotor symptoms like hot flashes and night sweats, commonly associated with menopause. Additionally, it leads to a decline in bone mineral density, muscle strength, mood, libido, and sexual function, among other effects impacting quality of life and physical health. HRT aims to mitigate these undesirable symptoms by supplementing the body's low hormone levels with exogenous estrogen, with or without progesterone.
The Efficacy of HRT
Dr. Attia emphasizes that Hormone Replacement Therapy is undeniably the most effective treatment available for easing menopause symptoms, thereby improving quality of life. The debate lies in whether this relief comes at the cost of raising one's risk of certain chronic diseases, particularly breast cancer, dementia, and cardiovascular disease.
The Timing of HRT
A point of broad consensus in the medical community is that HRT should only be initiated within the first ten years of the onset of menopause. Starting hormone therapy more than a decade after menopausal onset means experiencing a prolonged period of estrogen deprivation, which likely diminishes any potential benefits of HRT and may increase any potential risks.
The Risk-Benefit Analysis
The decision to initiate or continue HRT post-menopause boils down to a risk-benefit analysis. The best choice may vary across individuals based on factors such as menopausal symptom severity, family history, and personal preferences. Dr. Attia maintains that hormone therapy has substantial positive impacts beyond menopausal symptom relief and that the alleged risks associated with HRT are not supported by evidence, lack clinical significance, or otherwise fail to outweigh the benefits to health and quality of life.
HRT and Breast Cancer
The Women's Health Initiative (WHI) reported increased incidence of breast cancer in the group given conjugated equine estrogen (CEE) plus the progestogen medroxyprogesterone acetate (MPA). However, Dr. Attia points out that the opposing results with estrogen-only versus estrogen + MPA strongly suggest that MPA, and not estrogen, is responsible for any elevated risk observed in the WHI.
HRT and Bone Health
Estrogen is an essential hormone for maintaining bone density. When estrogen levels drop dramatically during menopause, the rate at which bone density drops increases and resistance training becomes less effective in stimulating bone regrowth. HRT, by keeping estrogen levels from dropping too low, prevents this loss and thus lowers the risk of potentially debilitating fractures.
HRT and Dementia
The WHI also reported higher rates of probable dementia with both estrogen alone and CEE + MPA relative to placebo groups. However, the age at which HRT is initiated may be a critical factor in this apparent risk.
HRT and Cardiovascular Disease
Menopause is associated with the development of a range of risk factors for cardiovascular disease (CVD), including increased visceral fat, reduced glucose tolerance, hypertension, and dyslipidemia. By replacing the estrogen deficit, hormone therapy could theoretically ameliorate some of these risks.
Dr. Attia concludes that the widespread panic over hormone therapy risks has not been remotely justified. He believes that the benefits of HRT often outweigh the risks. The reports of health risks are dubious at best, whereas the boons to menopause symptom relief, bone health, psychological and sexual wellbeing, and possibly risk mitigation for chronic diseases all have the potential to increase one's chances of living healthier, happier, and longer.
The Future of HRT
While most available data investigated HRT formulations which are now all but obsolete, and conducted trials in which interventions lasted only a few years, Dr. Attia argues that the cost of waiting for future trials to achieve a somewhat higher level of confidence must be weighed against the number of patients whose lives and health might be improved by starting or continuing HRT now.
The Role of Personalized Medicine
The best we can do is to weigh risks and benefits based on the evidence at hand and make a choice that has the highest probability of a positive outcome. This approach underscores the importance of personalized medicine, where treatment decisions are tailored to the individual patient's unique circumstances and needs.
The Need for Further Research
There is a need for further research on long-term HRT use and on newer HRT formulations like transdermal estradiol and micronized progesterone. However, the lack of long-term randomized trial data should not be a reason to deny patients potentially lifesaving treatments.
Dr. Peter Attia's perspective on HRT provides a comprehensive and nuanced understanding of the therapy's potential benefits and risks. It underscores the importance of individualized treatment decisions and the need for further research to continue improving women's health during perimenopause and menopause.
Explore Hormone Replacement Therapy with Joi
Joi has hormone treatment options that come as creams, troches, capsules, and injectables. We’ll work with you to customize a plan that best fits your individual needs. We also offer the option to mix personalized dosages into one cream for super easy application. Schedule a consultation today.Back to Blog